ArticleCell death & disease2018

Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.

Linfeng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.